{
    "Trade/Device Name(s)": [
        "Oral Fluid Amphetamine-Specific Enzyme Immunoassay",
        "Calibrators and Controls"
    ],
    "Submitter Information": "Lin-Zhi International, Inc.",
    "510(k) Number": "K063024",
    "Predicate Device Reference 510(k) Number(s)": [
        "K992918",
        "K050945",
        "K050988",
        "K051058"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "September 27, 2006",
    "Summary Letter Received Date": "October 2, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Drug Specific, Calibrators",
        "Single (Specified) Analyte Controls"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "d-amphetamine"
    ],
    "Specimen Type(s)": [
        "Saliva"
    ],
    "Specimen Container(s)": [
        "Salivette collector (manufactured by Sarstedt)"
    ],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Oral Fluid Amphetamine-Specific Enzyme Immunoassay, Calibrators and Controls for qualitative detection of amphetamine in saliva using homogeneous enzyme immunoassay technology.",
    "Indications for Use Summary": "For qualitative determination of amphetamine in human saliva at a cutoff of 45 ng/mL using oral fluid specimens collected with Salivette device, providing a preliminary result requiring confirmatory testing such as GC/MS.",
    "fda_folder": "Toxicology"
}